What BioOhio Annual Conference: 2020 Vision 2020 Visionaries: Ohio experts highlight opportunities and trends in their respective niches Keynote: BIO President & CEO Jim Greenwood discusses the future of biotech and the bioscience industry Workforce & Education: how industry can better utilize and customize community college programs for workforce, and how undergraduate and graduate programs […]

What: American Conference Institute’s Biotech Patents Conference:  Practical Strategies for Prosecuting and Litigating Biotech Patents in a Rapidly Shifting Legal Environment. The biotech industry faces massive, imminent, change with patent reform nearing passage, impending promulgation of biosimilar pathway regulations from the FDA, the continued evolution of case law from the Federal Circuit and an unusually […]

Huw G. Hallybone, a Partner at Carpmaels & Ransford, gave a talk at the BIO IP Counsels Committee Conference (IPCC) in Boston last week about allowable subject matter at the EPO. Article 53 Exceptions to patentability European patents shall not be granted in respect of: (a) inventions the commercial exploitation of which would be contrary to […]

At the BIO IP Counsels Committee Conference (IPCC) in Boston last week, Sandra Wells, VP and Chief IP Counsel of Affymetrix, gave a talk about the evolving patent-eligibility standards for genes. Earlier, the American Civil Liberties Union (ACLU), the Public Patent Foundation (PUBPAT), and a whole gaggle of others have filed a lawsuit challenging patents […]

I’m on my way to the BIO IP Counsels Committee Conference.  The 2010 Fall IPCC Conference, in Boston, MA, is scheduled for October 18-20, 2010.  It is an opportunity for BIO members and other industry IP professionals to come together to hear, discuss and learn about current and projected topics related to biotech IP. Program […]

BioPatent Design2010 Building a Robust, Secure Biological Patent to Ensure First Time Approval, Protect Product Revenue and Prevent Incoming Attack The area of BioPatent Design is rapidly evolving, with new developments sparking the Gene debate, developments in Biosimilars, protection issues with regards to DNA sequencing patents, vaccines and stem cells as well as new guidelines […]

The FDA and Xavier University have co-developed the first annual Global Outsourcing Conference to be held June 13-16, 2010. GOC 2010, which is billed as “being designed collaboratively by FDA, Innovator Companies, and Contract Organizations to address Global Outsourcing challenges that reside on all sides,” focuses on four key discussions: Global Compliance The “Business” of […]